Author:
Hofman Paul,Popper Helmut H.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine
Reference95 articles.
1. Committee on Policy Issues in the Clinical Development and Use of Biomarkers for Molecularly Targeted Therapies, Board on Health Care Services, Institute of Medicine, The National Academies of Sciences, Engineering, and Medicine; Graig LA, Phillips, JK, Moses, HL, editors. Biomarker tests for molecularly targeted therapies: key to unlocking precision medicine. Washington (DC): National Academies Press (US); 2016.
2. Prasad V, Fojo T, Brada M (2016) Precision oncology: origins, optimism, and potential. Lancet Oncol 17:e81–e86. doi: 10.1016/S1470-2045(15)00620-8
3. Shames DS, Wistuba II (2014) The evolving genomic classification of lung cancer. J Pathol 232:121–133
4. Al-Zaid T, Somaiah N, Lazar AJ (2014) Targeted therapies for sarcomas: new roles for the pathologist. Histopathology 64:119–133
5. Calabrese F, Lunardi F, Popper H (2015) Molecular diagnosis in lung diseases. Front Biosci (Landmark Ed) 20:644–688
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献